Yue Da International to Acquire 52% Stake in Organoid Technology Firm

MT Newswires Live

05/01

Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.

The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.

The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.

The parties are yet to enter into a formal agreement regarding the acquisitions.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2532713880"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2532713880\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2532713880?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-01 20:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2532713880","market":"sh","top_or_hot":-1,"title":"Yue Da International to Acquire 52% Stake in Organoid Technology Firm","media":"MT Newswires Live","content":"<html><body><p> Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.</p><p>The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.</p><p>The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.</p><p>The parties are yet to enter into a formal agreement regarding the acquisitions.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yue Da International to Acquire 52% Stake in Organoid Technology Firm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYue Da International to Acquire 52% Stake in Organoid Technology Firm\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-01 20:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.</p><p>The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.</p><p>The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.</p><p>The parties are yet to enter into a formal agreement regarding the acquisitions.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00629","symbol_name":"悦达国际控股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2532713880","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2532713880","pubTimestamp":1746101256,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Yue Da International  entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.The parties are yet to enter into a formal agreement regarding the acquisitions.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00629":"悦达国际控股","BK1186":"特殊金融服务"},"translate_title":"悦达国际将收购类器官技术公司52%股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00629":0.9},"content_text":"Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.The parties are yet to enter into a formal agreement regarding the acquisitions.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}